MYC and cancer: In the present study, amplification in MYC and AKT1 show a strong consistency with transcript levels and glycolysis-high tumors harbor increased MYC and AKT1 expression, suggesting that AKT1 and MYC activation contribute the glycolytic activation in some cancer type.